In the latest episode of ION Influencers Fireside Chat, Jonathan Lewis, Co-Founder of Sheridan Capital Partners, deep dived into the evolving world of healthcare private equity. The conversation moved past the noise of daily policy battles to focus on the fundamental tailwinds, niche opportunities, and hands-on value creation strategies defining success in the lower middle market.

With healthcare consuming nearly 20% of US GDP, Lewis explained why sector specialization is no longer a luxury but a necessity for investors seeking stable, long-term returns.

Here are the key topics discussed during the insightful session.

1. The Case for Healthcare: Demographics, Demand, and Efficiency

Lewis kicked off by outlining the undeniable macro tailwinds supporting healthcare investment. The US healthcare market is now a $5 trillion economy, driven primarily by an aging population and increasing acuity of care.

However, he noted that this growth presents a crisis of affordability. This paradox fuels innovation: the need to create more efficient delivery systems that improve patient outcomes while keeping systemic costs down. For investors, this dynamic creates a fertile ground for businesses that solve real problems in the care continuum.

2. Post-Pandemic Innovation: The Great Accelerator

While healthcare has traditionally been a technology laggard, Lewis highlighted the pandemic as a turning point. Clinic closures forced a massive leap in technology adoption, not just in telemedicine, but in how patients, providers, and payers interact.

Furthermore, post-COVID wage inflation acted as a catalyst. As labor costs soared, the entire healthcare system was forced to seek efficiency, making technology adoption not just convenient, but essential for survival.

3. Strategy: Avoiding Policy Noise and Finding “Clean” Demand

How does a firm invest in such a regulated space without getting burned by the next election? Lewis shared Sheridan’s core philosophy: don’t try to predict policy; avoid its impact altogether.

Instead of betting on areas subject to the “stroke of a pen,” Sheridan focuses on subsectors with fundamental, consumer-driven demand that are insulated from government reimbursement volatility.

Example: Oral Surgery
Lewis cited oral surgery as a perfect example. The demand for wisdom tooth extractions is predictable and perennial, driven by 8th, 9th, and 10th graders. Crucially, reimbursement is tied to dental insurance, not government programs, providing a long history of stability.

4. The Moat: Nuance, Relationships, and “Doers”

If the thesis is simple (invest in predictable areas), how does a firm differentiate? Lewis argued that the moat lies in understanding the nuance and subtleties of healthcare—the “read between the lines” insights that generalists miss. This comes from spending 100% of time in the sector, tuning into the right signals and ignoring the noise.

But the real differentiator is operational value creation. For Sheridan, this means moving beyond “thought leadership” to providing “helping hands.”

• Practical Execution: Installing new accounting software or a CRM for a portfolio company’s sales team.

• Founder-Centric Approach: Listening to founders to understand not just what solution to bring, but the cadence and integration strategy to ensure maximum impact with minimal disruption.

5. Sourcing Expertise: The Triangulation Method

Lewis provided a glimpse into how Sheridan builds its advisory network. The process is a blend of “shoe leather” research (attending trade shows) and strategic distillation. By canvassing a subsector, they listen for the same 3-5 names mentioned repeatedly by industry participants. These respected thought leaders become the partners who help underwrite the thesis and often serve on company boards post-acquisition.

6. The LP Perspective: From Tariffs to AI

What are limited partners worried about now versus five years ago? Lewis noted that recent annual meetings have been dominated by questions about “Liberation Day” tariffs (impacting supply chains) and the rise of AI (is it a help, a hindrance, or a threat?).

While Sheridan views AI as a “friend” that allows them to accomplish more work in the same time, LPs are increasingly focused on these macro “needle movers” that could change an outcome with a single stroke.

7. The Future of the Industry: Specialization and the Wealth Channel

Looking ten years out, Lewis predicted continued consolidation among asset managers. As capital concentrates among fewer names, GPs must sharpen their “right to win” and articulate a very specific value proposition.

He also acknowledged the unstoppable rise of the wealth channel. While institutional investors will remain the core due to their ability to underwrite complex strategies, the demand from individual investors for access to private markets and specialized alternative assets like healthcare is a trend that cannot be ignored.

Final Thought:
When asked about the role of advisors, Lewis emphasized that in the lower middle market, the most effective advisors are not Fortune 500 executives, but founders and operators who have sat in the same seat. For M&A advisers, he highlighted their crucial role in helping founder-owners navigate complex transactions, ensuring better outcomes for both the seller and the investor. “It always helps to have extra hands,” he concluded.

Key timestamps:

00:06 Introduction to the Fireside Chat
01:51 The Importance of Healthcare in Investment Portfolios
03:11 Innovation in Healthcare Delivery
04:33 Anticipating Future Healthcare Services
05:35 Navigating Regulations in Healthcare Investment
07:28 Examples of Resilient Healthcare Sub-Sectors
09:21 Creating Competitive Advantages in Healthcare Investment
12:57 Selecting Industry Experts for Advisory Roles
17:00 Evolving Questions from Limited Partners
18:22 Future of Asset Management and Specialization
21:20 The Role of Advisors in the Future Ecosystem
24:10 Conclusion and Closing Remarks